Noya .base.eth 💢π² 🪞🌶️ retweetledi
A creature unlike any other.
A dreamer, a disruptor … a … DEGEN.
777 supply. Free mint.
Q1 2026
Enter the dream → dream.degen.tips
English
Noya .base.eth 💢π² 🪞🌶️
8K posts
Noya .base.eth 💢π² 🪞🌶️
@EthFrai
☕ Coffee-fueled thoughts — share your recs! 🎧 Podcast junkie & sound explorer Nitrograph REFLECTED
Katılım Ekim 2021
6.6K Takip Edilen1.3K Takipçiler
Healthcare isn't just hospitals and prescriptions, it's trust, guidance, and human experience.
Your voice helps shape all of it.
Join me on @LifeNetwork_AI: testnet.lifeai.io/ref?code=LZZ00…
Code: LZZ0021
#LifeAITestnet #HealthcareAI
English
Noya .base.eth 💢π² 🪞🌶️ retweetledi
Noya .base.eth 💢π² 🪞🌶️ retweetledi
Imagine finding $4M on a table and all you had to do was click a few buttons.
That's literally what's happening with Watt2Trade's Rewards Program!
Remember: early movers (and traders) have the edge.
Start in less than 40 seconds with the video below!
English
Noya .base.eth 💢π² 🪞🌶️ retweetledi
Earn GUARANTEED allocation from the $4M Rewards Program ⚡
Enter our Official Alphabot Raffle now: alphabot.app/wattoinairdrop
The easiest bag you'll ever secure.
English
QAM
Noya .base.eth 💢π² 🪞🌶️ retweetledi
Lowkey tired of posting and watching the algo eat my work for an hour then move on.
That is why I started using @RallyOnChain.
If you have been thinking about building something real around your content, get on it:
waitlist.rally.fun/joinme/yourhan…
English
AI agents are great… until they disagree. In the Agent Economy, disputes aren’t a bug, they’re inevitable. If an agent misses an SLA or delivers bad data, who decides?That’s why internetcourt.org matters. jury with fast resolution time is exactly what this space needs.
English
"GitHub PR reviews are getting exhausting. With 43 million monthly pull requests (many AI-generated), nobody has time to properly review code. The result? Tired reviewers and low-quality code. @mergeproofapp introduces staked review to bring order and incentives to the process."
English
Most creator platforms reward numbers. Rally is different. It evaluates quality. That only works because @GenLayer enables AI validators to reach consensus on subjective things like originality and intent. Without that infrastructure, @RallyOnChain couldn’t function.
English
300 Strands claimed.
Real-world yield is coming to Solana with @SplyceFi
Feels good to be early.
Your turn: solana.splyce.finance/rewards?ref=1f…
English
Early access secured on @YeloNFT. Private OTC deals - BUILT FOR PRIVATE SETTLEMENT AND FLEXIBLE PAYMENT RAILS. . ordinals.trading
English
Just claimed my Red Envelope from @MeyReal_io 🧧
This is the time to stack units and climb the leaderboard (you'll thank me later, that's all I'll say).
25K jackpot hiding in some envelopes, claim yours now and find out if its yours → meyhub.io/?ref=VKUlXEJM6G
English
Healthy societies start with honest voices.
Be one of them.
Jump in with @LifeNetwork_AI: testnet.lifeai.io/ref?code=LZZ00…
Code: LZZ0021
#LifeAITestnet #HealthcareAI
English
LifeAI brings smart assistance to every corner of healthcare.
@LifeNetwork_AI #LifeAI #healthcareAI x.com/LifeNetwork_AI…
LIFE AI@LifeNetwork_AI
🩺 Community Question: In medical innovation, what drives greater long-term impact: U.S.-grade quality for rigorous validation and strict regulation or Asia-speed execution for faster approvals and rapid scale? Viewpoint A: U.S.-Grade Quality Through institutions like the U.S. Food and Drug Administration, the U.S. emphasizes deep clinical validation before approval. Rigor reduces risk, protects trust, and supports durable breakthrough innovation. Viewpoint B: Asia-Speed Execution Countries such as China and India accelerate approvals and deploy innovations at scale. Faster access can save lives, especially in high-burden diseases. 👇 Drop A or B and share your perspective.
English
Noya .base.eth 💢π² 🪞🌶️ retweetledi
🩺 Community Question:
In medical innovation, what drives greater long-term impact:
U.S.-grade quality for rigorous validation and strict regulation
or Asia-speed execution for faster approvals and rapid scale?
Viewpoint A: U.S.-Grade Quality
Through institutions like the U.S. Food and Drug Administration, the U.S. emphasizes deep clinical validation before approval.
Rigor reduces risk, protects trust, and supports durable breakthrough innovation.
Viewpoint B: Asia-Speed Execution
Countries such as China and India accelerate approvals and deploy innovations at scale.
Faster access can save lives, especially in high-burden diseases.
👇 Drop A or B and share your perspective.
English